CellFE

CellFE

Company developing a microfluidics based device to deliver gene-editing molecules.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor investor investor investor investor

€0.0

round
investor investor investor

€0.0

round
investor investor investor investor investor

€0.0

round
*

$22.0m

Series A
Total Funding000k
More about CellFE
Made with AI
Edit

CellFE is a biotechnology company focused on advancing cell therapies through innovative microfluidic cellular engineering technology. The company serves advanced cell therapy researchers and developers, operating in the biotechnology and healthcare markets. CellFE's business model revolves around providing cutting-edge solutions that enhance the manufacturing process of cell therapies, making them more potent, durable, and cost-effective. Revenue is generated through partnerships, licensing agreements, and direct sales of their proprietary technology. The company is dedicated to supporting cell therapy innovators in producing superior treatments for patients worldwide, leveraging a team of seasoned biotech experts and inventors.

Keywords: microfluidic technology, cell therapy, biotechnology, healthcare, manufacturing, cost-effective, potent treatments, durable therapies, partnerships, licensing.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo